Philips 2010 Annual Report Download - page 86

6 Sector performance 6.1.4 - 6.1.4
86 Annual Report 2010
October we completed Russia’s first installation of a
domestically made CT scanner at the Hospital of War
Veterans in St. Petersburg.
We have also made significant progress in developing
products that meet the varied needs of customers
around the world. In fact, since 2009, companies we
have acquired (primarily in emerging markets)
introduced 15 new products. An example is the Allura
FC catherization lab launched in India in 2010 – the first
product developed and manufactured by Alpha X-ray, a
recent Philips acquisition in India.
Implement strategy
•Move toward leadership position in imaging: In 2010 we
unveiled a new approach to clinical collaboration that
will drive innovation and efficiency in radiology: Imaging
2.0. Just as Web 2.0 redefined the way people connect,
share and use the internet, Imaging 2.0 represents a
new world of possibilities for radiology science. It is
about integration and collaboration, and new levels of
patient focus and safety that can help clinicians achieve
what was unimaginable just a few short years ago.
The introduction of Imaging 2.0 coincided with an
unprecedented number of new product introductions
in radiology, all designed to facilitate innovation and
collaboration, focus on patient care and safety, and
improve economic value. This year, Philips introduced
the Ingenuity CT platform, which is designed to provide
equivalent diagnostic image quality at up to 80% less
dose. This advanced technology has also been
incorporated into a new hybrid imaging system, the
Ingenuity PET/CT, used to conduct studies in oncology
imaging, cardiac perfusion and diagnostic CT.
Other innovations in imaging include:
- Ingenia MR, the first digital broadband MR system
that improves image quality while shortening MR
exam times by up to 30%
- Ingenuity PET/MR, the first new imaging modality
introduced in 10 years, which integrates the
molecular imaging capabilities of PET with the
superior soft tissue contrast of MR (magnetic
resonance imaging)
- IntelliSpace Portal, a new multimodality, multivendor
workstation that, for the first time, uses advanced
networking capabilities to facilitate collaboration
between radiologists and referring clinicians anytime,
anywhere, no matter the modality or vendor,
ultimately helping to fuel improved patient outcomes
- iU22 xMATRIX Ultrasound, a new ultrasound system
that allows clinicians to capture twice as much clinical
information in the same amount of time without
moving, turning or rotating the transducer, helping
clinicians make more informed care decisions, and
potentially minimizing the frequent repetitive stress
injuries experienced in the field of sonography.
•Grow Home Healthcare: Philips is expanding its Home
Healthcare business both by introducing new solutions,
as well as by expanding its footprint around the globe.
Seniors are living longer and remaining in their own
homes; however, falls have become an epidemic
problem that jeopardizes their chances to live
independently. In order to help enable continued
independence for seniors by improving access to help in
the event of a fall, we introduced the breakthrough
medical alert service, Philips Lifeline with AutoAlert.
Available in the US, Lifeline with AutoAlert can detect
falls – with a high rate of detection and low rate of false
alarms – and automatically call for help. We also
announced plans to make this enhanced service
available in Japan in 2011.
Additionally, there are more than one billion people
suffering from chronic respiratory diseases worldwide.
Of this group, an estimated 210 million people have
Chronic Obstructive Pulmonary Disease (COPD).
Three million people died from COPD in 2005, and 90%
of those deaths were in low and middle-income
countries, where effective strategies for prevention and
control are not always implemented or accessible.
Philips will train 2,000 physicians in emerging markets
on respiratory disease like sleep apnea and COPD. In
India, Philips recently supported the set-up of sleep labs
in hospitals to help diagnose sleep disorders and help
get affected patients the treatment needed to live a
healthier life.
•Continue to execute our care cycle strategy around women’s
health, cardiology and oncology: we are concentrating our
effort, investment and research on some of the most
significant diseases and conditions within those areas.
With a growing presence in these fields, we focus on
the fundamental health problems with which people are
confronted today – diseases such as congestive heart
failure, breast and other cancers, coronary artery
disease.
•Leverage Sustainability as a driver of growth: We are
making significant strategic investments in our industrial
footprint in emerging markets in order to drive growth
by better serving local customers and to reduce our
overall cost position. In 2010, we invested EUR 60
million in Green Innovation and the share of Green
Product sales increased from 23% in 2009 to 25% in
2010. We continue to focus our Green Innovation
projects on lowering energy usage, weight, radiation